Back to search

Article

In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains

2021-04-23

Abstract excerpt

<title>Abstract</title> <p>Rapidly-emerging variants jeopardize antibody-based countermeasures against SARS-CoV-2. While recent cell culture experiments have demonstrated loss of potency of several anti-spike neutralizing antibodies against SARS-CoV-2 variant strains1-3, the in vivo significance of these results remains uncertain. Here, using a panel of monoclonal antibodies (mAbs) corresponding to many in advanc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
aeededab-caa1-5497-820d-4c0936c0f826
DOI
10.21203/rs.3.rs-448370/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strainsDOI 10.21203/rs.3.rs-448370/v1
SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodiesSemantic proximity
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies.Semantic proximity
The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variantsSemantic proximity
The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.Semantic proximity
The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against novel viral variantsSemantic proximity
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by several therapeutic monoclonal antibodiesSemantic proximity
Antibodies that neutralize all current SARS-CoV-2 variants of concern by conformational lockingSemantic proximity
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern.Semantic proximity
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strainsSemantic proximity
Antibody cocktail effective against variants of SARS-CoV-2Semantic proximity
Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infectionSemantic proximity
Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domainSemantic proximity
Select a neighboring publication to make it the new centre.